(Q42659988)

4 November 2017

Colon perforation during antiangiogenic therapy for malignant glioma (English)

1 reference

4 November 2017

angiogenesis inhibitor

1 reference

7

Patrick Y Wen

1 reference

4 November 2017

Andrew D Norden

1

1 reference

4 November 2017

Jan Drappatz

2

1 reference

4 November 2017

Abigail Slate Ciampa

3

1 reference

4 November 2017

Lisa Doherty

4

1 reference

4 November 2017

Debra Conrad LaFrankie

5

1 reference

4 November 2017

Santosh Kesari

6

1 reference

4 November 2017

29 August 2008

1 reference

4 November 2017

1 reference

4 November 2017

11

1 reference

4 November 2017

92-95

1 reference

4 November 2017

1

1 reference

Management of bevacizumab-associated bowel perforation: a case series and review of the literature

4 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Gastrointestinal perforation due to bevacizumab in colorectal cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Sigmoid diverticular perforation in neurosurgical patients receiving high-dose corticosteroids

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Use of corticosteroids in neuro-oncology

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718964

Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18757774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1215/15228517-2008-071

1 reference

4 November 2017

1 reference

4 November 2017

1 reference